Global G-CSF Biosimilars Market Study 2016-2026, by Segment (Human Growth Hormone, Erythropoietin, ), by Market (Blood Disorders, Oncology Diseases, ), by Company (Pfizer, Novartis, )

October 2019 | 59 pages | ID: G27B4F6CFD52EN
99Strategy

Abstracts

SUMMARY

The global G-CSF Biosimilars market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Human Growth Hormone
• Erythropoietin
• Monoclonal Antibodies
• Insulin
• Interferon
• Granulocyte-Colony Stimulating Factor

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Blood Disorders
• Oncology Diseases
• Chronic And Autoimmune Diseases
• Growth Hormone Deficiencies

Company Coverage (Sales data, Main Products & Services etc.):

• Pfizer
• Novartis
• Roche
• Merck & Co.
• Sanofi
• Johnson & Johnson
• Gilead Science
• GlaxoSmithKline
• AbbVie
• Amgen
• AstraZeneca
• Bayer

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 G-CSF Biosimilars Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 G-CSF BIOSIMILARS MARKET BY TYPE

2.1 By Type
  2.1.1 Human Growth Hormone
  2.1.2 Erythropoietin
  2.1.3 Monoclonal Antibodies
  2.1.4 Insulin
  2.1.5 Interferon
  2.1.6 Granulocyte-Colony Stimulating Factor
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Blood Disorders
  3.1.2 Oncology Diseases
  3.1.3 Chronic And Autoimmune Diseases
  3.1.4 Growth Hormone Deficiencies
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Pfizer (Company Profile, Sales Data etc.)
5.2 Novartis (Company Profile, Sales Data etc.)
5.3 Roche (Company Profile, Sales Data etc.)
5.4 Merck & Co. (Company Profile, Sales Data etc.)
5.5 Sanofi (Company Profile, Sales Data etc.)
5.6 Johnson & Johnson (Company Profile, Sales Data etc.)
5.7 Gilead Science (Company Profile, Sales Data etc.)
5.8 GlaxoSmithKline (Company Profile, Sales Data etc.)
5.9 AbbVie (Company Profile, Sales Data etc.)
5.10 Amgen (Company Profile, Sales Data etc.)
5.11 AstraZeneca (Company Profile, Sales Data etc.)
5.12 Bayer (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global G-CSF Biosimilars Market 2016-2019, by Type, in USD Million
Table Global G-CSF Biosimilars Market 2016-2019, by Type, in Volume
Table Global G-CSF Biosimilars Market Forecast 2020-2026, by Type, in USD Million
Table Global G-CSF Biosimilars Market Forecast 2020-2026, by Type, in Volume
Table Global G-CSF Biosimilars Demand 2016-2019, in USD Million
Table Global G-CSF Biosimilars Demand 2016-2019, in Volume
Table Global G-CSF Biosimilars Demand Forecast 2020-2026, in USD Million
Table Global G-CSF Biosimilars Demand Forecast 2020-2026, in Volume
Table Global G-CSF Biosimilars Market Size & Growth 2016-2019, in USD Million
Table Global G-CSF Biosimilars Market Size & Growth 2016-2019, in Volume
Table Global G-CSF Biosimilars Market Forecast 2020-2026, in USD Million
Table Global G-CSF Biosimilars Market Forecast 2020-2026, in Volume
Table Global G-CSF Biosimilars Market 2016-2019, by Region, in USD Million
Table Global G-CSF Biosimilars Market 2016-2019, by Region, in Volume
Table Global G-CSF Biosimilars Market Forecast 2020-2026, by Region, in USD Million
Table Global G-CSF Biosimilars Market Forecast 2020-2026, by Region, in Volume
Table Pfizer Overview List
Table G-CSF Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table G-CSF Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table G-CSF Biosimilars Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table G-CSF Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Overview List
Table G-CSF Biosimilars Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table G-CSF Biosimilars Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table G-CSF Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Science Overview List
Table G-CSF Biosimilars Business Operation of Gilead Science (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table G-CSF Biosimilars Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table G-CSF Biosimilars Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table G-CSF Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table G-CSF Biosimilars Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table G-CSF Biosimilars Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global G-CSF Biosimilars Market Growth 2016-2019, by Type, in USD Million
Figure Global G-CSF Biosimilars Market Growth 2016-2019, by Type, in Volume